Treatment effects monitoring committees and early stopping in large clinical trials

Clinical Trials

Volumn 1, Issue 1, 2004, Pages 40-47

  Kiri, Antariksha ^a   Tonascia, Susan ^b   Meinert, Curtis L ^c  

^a Punta Gorda   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL TRIAL; FINANCIAL MANAGEMENT; HUMAN; METHODOLOGY; ORGANIZATION AND MANAGEMENT; OUTCOME ASSESSMENT; PROFESSIONAL STANDARD; PUBLICATION; QUESTIONNAIRE; STATISTICS; TREATMENT OUTCOME;

CLINICAL TRIALS; CLINICAL TRIALS DATA MONITORING COMMITTEES; HUMANS; OUTCOME ASSESSMENT (HEALTH CARE); PERIODICALS; QUESTIONNAIRES; RESEARCH DESIGN; RESEARCH SUPPORT; TREATMENT OUTCOME;

EID: 14744302255     PISSN: 17407745     EISSN: None     Source Type: Journal    
DOI: 10.1191/1740774504cn014oa     Document Type: Article

References (10)

1. Meinert CL. Clinical trials dictionary: terminology and usage recommendations. Baltimore: The Johns Hopkins Center for Clinical Trials, 1996.
2. Ellenberg S, Geller N, Simon R, Yusuf S. Practical issues in data monitoring of clinical trials. Bethesda, Maryland, USA, 27–28 January 1992. Stat Med 1993; 12: 414–616.
3. Ellenberg S., Fleming T., DeMets DL. Data monitoring committees in clinical trials: a practical perspective. Chichester: John Wiley & Sons, Ltd, 2002.
4. Kiri A. Treatment effects monitoring in clinical trials. PhD dissertation, Johns Hopkins University, 151 pp. University of Michigan Digital Dissertations, Publ. No. AAT 9964129, 2000.
5. European Agency for the Evaluation of Medicinal Products, Human Medicines Evaluation Unit. International Conference on Harmonization: ICH Topic E9: Statistical Principles for Clinical Step 4, Consensus guideline. http://www.emea.eu.int/htms/human/ic/efficacy/ichfin.htm. Last accessed 5 February 1998.
6. Greenberg B. Organization, review, and administration of cooperative studies: a report from the Heart Special Project Committee of the National Advisory Heart Council, May 1967. Control Clin Trials 1988; 9: 137–148.
7. Gordon R. Clinical trial activity: recommendations. NIH Guide Grants Contracts 1979; 8: 29.
8. National Institutes of Health. NIH policy for data and safety monitoring. http//grants1.nih.gov/grants/guide/notice-files/not98-084.html. Last accessed 10 June 1998.
9. Meinert C.L. Masked monitoring in clinical trials – blind stupidity? New Engl J Med 1998; 338: 1381–1382.
10. Moher D., Schulz K., Altman D. for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. J Am Med Assoc 2001; 285: 1987–1991.